Conference Call with Apollo Hospitals Enterprise Management and Analysts on Q1FY26 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Facilities company Apollo Hospitals Enterprise announced Q1FY26 results Revenues at Rs 5,842 crore vs Rs 5,086 crore in Q1FY25; growth of 15% YoY. EBITDA at Rs 852 crore vs Rs 675 crore in Q1FY25. This is after Apollo 24/7 cost of Rs 121 crore in the quarter (incl. Rs 24 crore non-cash ESOP charge) vs Rs 150 crore in Q1FY25. Reported PAT at Rs 433 crore vs Rs 305 crore in Q1FY25 Diluted EPS of Rs 30.10 per share in Q1FY26 (not annualised). Prathap C Reddy, Chairman, Apollo Hospitals Enterprise Ltd. said: ''I am proud to see the resilient comeback in the first quarter of FY26, building on the strong foundation of Q4FY25. I am glad to inform you that Q1FY26 has delivered another robust set of results, with revenue growth in the double digits at 15% YoY and continued improvement in margins. Our performance demonstrates the power and resilience of our integrated model of healthcare delivery, with all three engines - our core divisions, Healthcare Services, Retail Healthcare & Diagnostics, and Digital & Pharma Distribution- contributing to our performance. Patient numbers across our network increased year-on-year, reflecting both the deeper penetration of our Centres of Excellence and the growing confidence of communities in our integrated care model. The quarter saw us announce our ambitious growth strategy to add over 4,300 beds in the next five years with an investment of over ~7,600 crore. The first phase of 2,000 beds is already in progress. We have added an existing 200-bed hospital in Bengaluru and will also be establishing a 500-bed greenfield hospital in the suburbs of the city to bring the total bed strength in Bengaluru to 1,500 beds. In Hyderabad, we are adding 160 beds at our existing Jubilee Hills and Secunderabad facilities, and with the upcoming facility in Gachibowli, our bed strength in the city will increase to 1,400 beds. On the digital front, Apollo 24/7 achieved a quarterly GMV of over Rs 682 crore, sustaining the platform's momentum and signalling the continuing strong demand for teleconsultations, lab and pharmacy deliveries. This performance builds on the platform's FY25 GMV of Rs 3,007 crore, demonstrating our success in creating a seamless care continuum from home to hospital. The demerger of our digital health and pharmacy business, approved in the last quarter, is now in the implementation phase. This strategic move will enable focused capital allocation and sharper growth plans with dedicated management teams for both hospital operations and the omnichannel healthcare ecosystem, a structure designed to maximise synergies while preserving the Apollo ethos of quality and trust. Preventive healthcare remains at the heart of our mission. Through the AI-based Apollo ProHealth platform, we have crossed 25Million health assessments this quarter alone, guiding individuals on personalised wellness journeys and strengthening early-detection pathways. Patient access continues to guide our investments. We expanded our 'Care-Within-Reach' financing programs to additional tier 2 and tier 3 markets, ensuring that advanced treatments remain accessible to a broad segment of the population. Our efforts on sustainability saw us launch 'Green Health' initiatives in Mumbai and Hyderabad, achieving a 20% reduction in energy consumption per patient day and using eco-friendly materials across new construction projects. Looking ahead, we anticipate continued double-digit revenue growth for FY26, underpinned by new hospital openings in Patna and Jaipur slated for QJ, further digital innovation, and deepening partnerships with state governments to bolster community-based health initiatives. I remain confident that Apollo will set new benchmarks in clinical excellence, patient experience, and sustainable growth-true to our founding mission of enabling healthier, happier lives for all." Result PDF